Contemporary Management of Cardioembolic Stroke in Young Adults
DOI:
https://doi.org/10.33178/SMJ.2026.9Abstract
Cardioembolic stroke is a major cause of ischaemic stroke, arising from emboli of cardiac origin and carrying a substantial risk of recurrent events. In young adults, ischaemic stroke is less common than in older populations but is associated with a disproportionate lifetime burden of disability and mortality. The aetiological profile of this group is relatively different from older patients, with a higher contribution by cardioembolic and non-atherosclerotic factors, including structural cardiac abnormalities, occult atrial fibrillation (AF), and patent foramen ovale (PFO)(Ohya et al. 2022).
This narrative review examines the major aetiologies of cardioembolic stroke in young adults, with a focus on cardiovascular pathophysiology and management. Clinical recognition challenges are identified as presenting characteristics are frequently nonspecific and insufficient to adequately differentiate cardioembolic stroke from other ischaemic subtypes. (Marcoff and Homma 2014). This review will discuss diagnostic strategies such as electrocardiography, cardiac imaging, and prolonged rhythm monitoring (Stack and Cole 2017).
Management and secondary prevention strategies are discussed, however much of the available evidence relies on extrapolation from older populations. While advances in diagnosis and risk stratification have increased detection of cardioembolic causes, age-based findings are still lacking to assist in determining the best management strategies (Bukhari et al. 2023). This review discusses the importance of mechanism-driven individualised approaches to reduce recurrent stroke risk for cardioembolic ischaemic stroke in young adults.
References
1. Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, et al. Causes of ischaemic stroke in young adults versus non-young adults: a multicenter hospital-based observational study. PLoS One. 2022;17(7):e0268481. doi:10.1371/journal.pone.0268481.
2. Bukhari S, Yaghi S, Bashir Z. Stroke in young adults. J Clin Med. 2023;12(15):4999. doi:10.3390/jcm12154999.
3. Poisson SN, Hills NK, Sidney S, Fullerton HJ. Prevalence of atherosclerotic risk factors among children and young adults with arterial ischaemic stroke. JAMA Neurol. 2022 Aug 1.
4. Sharobeam A, et al. Patterns of infarction on MRI in patients with acute ischaemic stroke and cardio-embolism: a systematic review and meta-analysis. Front Neurol. 2020;11:606521. doi:10.3389/fneur.2020.606521.
5. Lansberg MG, et al. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology. 2000;54(8):1557-61. doi:10.1212/WNL.54.8.1557.
6. Rubiera M, Aires A, Antonenko K, Lémeret S, Nolte CH, Putaala J, et al. European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin. Eur Stroke J. 2022 Jun 3;239698732210994.
7. Shafiq A, et al. The role of echocardiography in cryptogenic stroke: a contemporary review. Future Cardiol. 2025;21(12):1117-27. doi:10.1080/14796678.2025.2550896.
8. Stack CA, Cole JW. A diagnostic approach to stroke in young adults. Curr Treat Options Cardiovasc Med. 2017;19(11):84. doi:10.1007/s11936-017-0587-6.
9. Bangad A, et al. Secondary ischaemic stroke prevention. Neurotherapeutics. 2023;20(3):721-31. doi:10.1007/s13311-023-01352-w.
10. Giralt-Steinhauer E, et al. Patent foramen ovale diagnosis in young stroke patients: analysis of recurrence and mortality. J Neurol. 2025;272:456. doi:10.1007/s00415-025-13178-x
11. Topcuoglu MA, et al. Updates on prevention of cardioembolic strokes. J Stroke. 2018;20(2):180-96. doi:10.5853/jos.2018.00780.
12. Mir H, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence. BMJ Open. 2018;8(7):e023761. doi:10.1136/bmjopen-2018-023761.
13. Mohamed WS, et al. Cardio embolic stroke and blood biomarkers: diagnosis and predictors of short-term outcome. Egypt J Neurol Psychiatry Neurosurg. 2019;55(1):68. doi:10.1186/s41983-019-0102-y.
14. Marcoff L, Homma S. Cardiac and aortic embolism. In: Reference Module in Neuroscience and Biobehavioral Psychology. Elsevier; 2017. doi:10.1016/B978-0-12-809324-5.04162-6.
15. Spence JD. Management of patients with embolic stroke of unknown source: interpreting the evidence in the light of clinical judgement. Curr Neurol Neurosci Rep. 2022;22(7):389-93. doi:10.1007/s11910-022-01202-w.
16. Singhal AB, Biller J, Elkind MS, Fullerton HJ, Jauch EC, Kittner SJ, et al. Recognition and management of stroke in young adults and adolescents. Neurology. 2013;81(12):1089-97. doi:10.1212/WNL.0b013e3182a4a451.
17. George MG. Risk factors for ischaemic stroke in younger adults. Stroke. 2020;51(3):729-35. doi:10.1161/STROKEAHA.119.024156.
18. Mussa R, Ambler G, Ozkan H, Mitchell J, Banerjee G, Leff AP, et al. Patient-reported outcomes after stroke in young adults: University College London Young Stroke Systematic Evaluation Study (ULYSSES). J Neurol Neurosurg Psychiatry. 2025;97(1):3-12. doi:10.1136/jnnp-2025-336411.
Published
License
Copyright (c) 2026 Khin May Phoo Thwe, Akshaya Indrakumar , Laneash Daniella E De Sousa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
